fluorouracil and Articulation Disorders
fluorouracil has been researched along with Articulation Disorders in 1 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Articulation Disorders: Disorders of the quality of speech characterized by the substitution, omission, distortion, and addition of phonemes.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Capecitabine plus lapatinib combination is an effective chemotherapy regimen in patients with advanced breast cancer." | 7.81 | Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer. ( Akça, Z; Büyükçelik, A; Erden, A; Mutlu, H, 2015) |
| "Capecitabine plus lapatinib combination is an effective chemotherapy regimen in patients with advanced breast cancer." | 3.81 | Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer. ( Akça, Z; Büyükçelik, A; Erden, A; Mutlu, H, 2015) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Mutlu, H | 1 |
| Büyükçelik, A | 1 |
| Akça, Z | 1 |
| Erden, A | 1 |
Other Studies
1 other study available for fluorouracil and Articulation Disorders
| Article | Year |
|---|---|
Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer.
Topics: Antineoplastic Agents; Articulation Disorders; Breast Neoplasms; Capecitabine; Deoxycytidine; Drug T | 2015 |